Efficacy of baricitinib 4 mg in patients with moderate‐to‐severe atopic dermatitis previously treated with systemic therapy

Abstract Background The Janus kinase (JAK)1/JAK2 inhibitor baricitinib in combination with topical corticosteroids (TCS) improved moderate‐to‐severe atopic dermatitis (AD) in the phase 3 BREEZE‐AD7 trial. Patients with previous systemic therapy may have more severe, treatment‐resistant disease. Obje...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonio Costanzo (Author), Akio Tanaka (Author), Tiago Torres (Author), Bibiana Pérez‐García (Author), Angelina Sontag (Author), Yun‐Fei Chen (Author), Fan Emily Yang (Author), Jill Kolodsick (Author), Hitoe Torisu‐Itakura (Author), Najwa Somani (Author)
Format: Book
Published: Wiley, 2023-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available